I believe the Canadian cost for the name brand drug is around $300-400/month, and some articles indicate a cost of $319/mo in Japan. Apparently the costs for a similar drug, ozempic, are even more of a stark contrast, at around $1000/mo domestically, and $100/mo internationally.

This is a black market created entirely due to the greed of Eli Lily and Novo Nordisk. That if this class of drugs were priced fairly in the United States, the black market would not have had a chance to take root. Pricing them fairly would reduce the reliance on sketchy compounding pharmacies, and would improve the safety of American patients. Failure to do so at this point is actively harming people out of pure greed, which is nothing new.

I can’t help but cheer for compounding pharmacies for fighting these greedy goliaths, and I hope their actions harm Eli Lily and Novo Nordisk as much as possible. I hope it ushers in an era of pirate medicine that erodes drug maker profits permanently.

I’m honestly a little surprised he hasn’t started promoting snake oil treatments for autism. Ivermectin, now for autism.

It very well could be an expensive gimmick, their last Zima boards certainly were. As for the selling of your information, thank you for the warning.

External PCIe seems to be their selling point. Also, why not welcome competitive form factors and options? That is, of course, if it’s competitive. No pricing in this article, but if I had to imagine they’re probably going to retail near $300, but I don’t think they’ll be competitive with sub $150 n150 machines at that price point.